MedPath

The clinical impact of using bicarbonate ion bath tablet on the management of dermatopathy due to EGFR-TKI in the patients with non-small cell lung cancer.

Phase 1
Conditions
The patients with non-small cell lung cancer who develop the dermatopathy due to EGFR-TKI.
Registration Number
JPRN-UMIN000023799
Lead Sponsor
ational Hospital Organization Disaster Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

The patients with the history of dermatologic disorder prior to the introduction of EGFR-TKI, for example, atopic dermatitis. Females with pregnacy and lactation. Those whom the attending physicians consider not suitable to the clinical study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath